AIMS: To evaluate the clinical inference of serum alpha-fetoprotein (AFP) response in
hepatocellular carcinoma (HCC) patients undergoing percutaneous radiofrequency ablation …

Aim Recurrence of hepatocellular carcinoma (HCC) is observed frequently, even after
curative treatments. The aim of this study is to elucidate the risk factors for recurrence of …

Abstract Background and Aim: To assess the significance of adequate α‐fetoprotein
decrease in monitoring the treatment effects of radiofrequency ablation (RFA) in …

Abstract Background and Aim The performance of alpha‐fetoprotein (AFP) in the detection
of hepatocellular carcinoma (HCC) recurrence after radiofrequency ablation was analyzed …

Radiofrequency ablation (RFA) is an effective local treatment for curative intent in patients
with cirrhosis of the liver and hepatocellular carcinoma (HCC) with diameter< 3 cm. Several …

Background We evaluated treatment modalities and survival in patients with hepatocellular
carcinoma (HCC), by pre-treatment and 3-month post-treatment serum alpha-fetoprotein …

Results Multivariate analysis revealed that of the three tumor makers only AFP-L3 showed
significant differences in the survival and disease-free rates. Conclusions AFP-L3 is the most …

Introduction Tumor burden score (TBS) was proposed to represent tumor burden in solid
tumors, including hepatocellular carcinoma (HCC). The prognostic role of TBS in HCC …

Objective Percutaneous radiofrequency ablation (RFA) is one of the first-line curative
therapies for hepatocellular carcinoma (HCC), but factors affecting the prognosis remain …

Radiofrequency ablation (RFA) is considered the most effective treatment for early‐stage
hepatocellular carcinoma (HCC) patients unsuitable for resection. However, poor outcome …